Phathom Pharmaceuticals (PHAT) PT Lowered to $44 at Needham & Company to Reflect vonoprazan Launch Dynamic, "Remain Confident in the Commercial Potential"
Go back to Phathom Pharmaceuticals (PHAT) PT Lowered to $44 at Needham & Company to Reflect vonoprazan Launch Dynamic, "Remain Confident in the Commercial Potential"| (NASDAQ: PHAT) | Delayed: 9.04 -0.13 (1.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.17 | 52 Week High | $ | |||
| Open | $9.25 | 52 Week Low | $ | |||
| Day High | $9.39 | P/E | N/A | |||
| Day Low | $9.02 | EPS | $ | |||
| Volume | 336,034 | |||||

